UT Health San Antonio, UTSA scientists use AI to reimagine personalized dental care
July 16, 2025
Every dental patient is different and even small improvements in dental materials can have a big impact on their care. But selecting the best products to ensure long-term, reliable results can involve time-intensive trial and error. A collaboration bet …
Dr. Kurmasheva awarded CURE foundation grant for childhood cancer research
July 16, 2025
A cancer diagnosis is always devastating and is especially overwhelming when the patient is a child. This is why the CURE Childhood Cancer Foundation is on a mission to advance research that will bring an end to childhood cancers. Recently, Raushan Kur …
Be Well Texas at UT Health San Antonio to lead major statewide expansion of opioid use disorder and recovery services
July 16, 2025
Treatment access, improvements will reach both rural and urban communities The Texas Health and Human Services Commission has formally announced that Be Well Texas, an initiative of the Be Well Institute on Substance Use and Related Disorders at UT Hea …
Be Well Texas at UT Health San Antonio to lead major statewide expansion of opioid use disorder and recovery services
July 16, 2025
Treatment access, improvements will reach both rural and urban communities Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, July 16, 2025 – The Texas Health and Human Services Commission has formally announced that Be Well Texas, an …
Morningstar: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
July 10, 2025
Morningstar: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Benzinga: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
July 10, 2025
Benzinga: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Nasdaq: Plus Therapeutics Initiates ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases Treatment
July 10, 2025
Nasdaq: Plus Therapeutics Initiates ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases Treatment
Yahoo! Finance: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
July 10, 2025
Yahoo! Finance: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
KSAT 12: If you were injured during the Hill Country floods, watch out for these symptoms (July 10)
July 10, 2025
KSAT 12: If you were injured during the Hill Country floods, watch out for these symptoms
KSAT 12: If you were injured during the Hill Country floods, watch out for these symptoms (July 9)
July 9, 2025
KSAT 12: If you were injured during the Hill Country floods, watch out for these symptoms